The potential anti-cancer strategies targeting P450 inhibition were postulated as: (i) preventing the conversion of environmental procarcinogens to active carcinogens; (ii) preventing the conversion of hormonal precursors to carcinogenic hormone derivatives; and (iii) preventing the metabolic inactivation of anti-cancer drugs [15]. The gene discussed is CYP2B6; the disease is cancer.